Rethinking Patient Selection in the Era of Advanced Hybrid Closed-Loop Systems

Rethinking Patient Selection in the Era of Advanced Hybrid Closed-Loop Systems

On September 28th, scientists and clinicians who have been closely involved in the development and launch of Control-IQ technology for the t:slim X2 insulin pump discussed patient selection in the era of advanced hybrid closed-loop systems at the EASD 2021 Virtual Conference. This presentation includes best practices for your clinic and recent patient reported outcomes. Time was set aside at the end for a live question and answer session.